Device / Technology News

RSS

NGS mutational testing can help detect patients with Barrett's esophagus

Barrett's esophagus (BE) develops in a subset of patients with gastroesophageal reflux disease (GERD) and can increase the risk of developing cancer of the esophagus. Although periodic surveillance for cancer is recommended for BE patients, these examinations may fail to identify pre-cancerous dysplasia and early cancers.

9 Jun 2015

Researchers develop device to diagnose bacterial meningitis in babies

Currently the only test to diagnose bacterial meningitis in babies is through a lumbar puncture, a painful and difficult procedure to perform. For this reason, a group of biomedical engineers decided to search for an alternative and developed a portable device that can detect this illness with a simple ultrasound scan of the fontanelle.

9 Jun 2015

Electroporation technique brings higher efficiency, higher throughput genome engineering in animal models

Jackson Laboratory researchers have shown that using an electric current to deliver the CRISPR/Cas9 system, in order to engineer genetic changes in laboratory mice, is highly efficient and significantly improves the system's throughput.

9 Jun 2015

Simulator-based driver assessment differentiates between skilled and non-skilled drivers

Passing the state driver's licensing test does not always mean new drivers have the critical skills they need to drive safely.

9 Jun 2015

Molecular Health, TestAnalytika sign distribution agreement for TreatmentMAP in Latin American region

Molecular Health signed an agreement with TestAnalytika to be its preferred distributor in the Latin American region at the 2015 ASCO Annual Meeting. TestAnalytika will begin to market and distribute Molecular Health's cancer treatment decision support product, TreatmentMAP, to patients, physicians, hospitals, laboratories, cancer centers and insurers in Latin America later this year.

8 Jun 2015

EMR Direct's phiMail Server software achieves ONC-HIT 2014 Edition Modular Certification

EMR Direct, a Health Information Service Provider (HISP) and leading developer of Direct messaging software for the secure exchange of Protected Health Information (PHI) over the Internet, announced today that its phiMail Server software has achieved Office of the National Coordinator for Health Information Technology (ONC-HIT) 2014 Edition Modular Certification via Drummond Group LLC, an Authorized Certification Body (ACB).

8 Jun 2015

Breathe NIOV System improves exercise duration among patients with chronic respiratory disease

Breathe Technologies, a developer and manufacturer of innovative medical technologies for patients with respiratory insufficiency diseases and neuromuscular diseases, announced new data today demonstrating that use of its Non-Invasive Open Ventilation (NIOV) System in pulmonary rehabilitation was associated with significant improvement in mean exercise duration change (approximately 63 percent) among patients with chronic respiratory disease.

8 Jun 2015

Clinical data of Trovagene's Precision Cancer Monitoring platform to be presented at two medical conferences

Trovagene, Inc., a developer of cell-free molecular diagnostics, announced today that clinical data featuring its Precision Cancer MonitoringSM platform will be presented at the 2015 Cancer Markers and Liquid Biopsies conference in San Diego, CA on June 11-12, and at the AACR Precision Medicine Series: Integrating Clinical Genomics and Cancer Therapy in Salt Lake City, UT on June 13-16.

8 Jun 2015

Merck KGaA, Darmstadt, Germany forms Global Fertility Alliance with Illumina and Genea

Merck KGaA, Darmstadt, Germany, a leading company for innovative and top-quality high-tech products in healthcare, life science and performance materials today announced the formation of the Global Fertility Alliance, a new collaboration to advance excellence in fertility technologies and processes within the assisted reproductive treatment (ART) laboratory.

From Illumina, Inc. 8 Jun 2015

Study: Non-invasive prenatal testing works in women at high risk of having babies with Down's syndrome

Results from a national study of non-invasive prenatal testing (NIPT) in women at high risk of having a baby with Down's syndrome will be presented at the annual conference of the European Society of Human Genetics today (Saturday).

8 Jun 2015

Non-invasive prenatal testing for Down's syndrome acceptable to parents

Non-invasive prenatal testing (NIPT) for Down's syndrome is feasible, acceptable to parents, and could be introduced into the National Health Service, UK researchers say. The results of a National Institute for Health Research study carried out by the first NHS laboratory to provide NIPT testing will be reported to the annual conference of the European Society of Human Genetics today (Saturday).

8 Jun 2015

Non-invasive prenatal testing can detect maternal cancer at early stage

Non-invasive prenatal testing (NIPT) for chromosomal foetal disorders is used increasingly to test for conditions such as Down's syndrome. NIPT examines DNA from the foetus in the mother's blood, and therefore does not carry the risk of miscarriage involved in invasive testing methods.

7 Jun 2015

Mountain River Physical Therapy chooses Clinicient's PracticeInsight cloud-based EMR and billing software

Clinicient Inc., a leader in outpatient rehabilitation business solutions, today announced that Mountain River Physical Therapy, a premier provider of personalized orthopedic, sports and industrial rehabilitation in West Virginia, Pennsylvania, Ohio, Virginia and Florida, selected Clinicient's PracticeInsight cloud based electronic medical record (EMR) and billing software.

7 Jun 2015

Physicians at UH Case Medical Center implant revolutionary device to treat right ventricular heart disease

University Hospitals Case Medical Center physicians in the Harrington Heart & Vascular Institute were the first in the state of Ohio to implant a revolutionary device to treat right ventricular heart disease.

5 Jun 2015

Seven NHS Trusts shortlisted for UK-wide healthcare award

Innovative partnership involving Sheffield Teaching Hospitals NHS Foundation Trust enables vital test reports to be shared across South Yorkshire, Mid Yorkshire and North Derbyshire for the benefit of 2.3million patients.

5 Jun 2015

Study can help spur beneficial lifestyle changes in patients to reduce Alzheimer's risk

Armed with new knowledge about how neurodegenerative diseases alter brain structures, increasing numbers of neurologists, psychiatrists and other clinicians are adopting quantitative brain imaging as a tool to measure and help manage cognitive declines in patients. These imaging findings can help spur beneficial lifestyle changes in patients to reduce risk for Alzheimer's disease.

5 Jun 2015

New Tel Aviv University research introduces promising new tool to combat antibiotic-resistant pathogens

At its annual assembly in Geneva last week, the World Health Organization approved a radical and far-reaching plan to slow the rapid, extensive spread of antibiotic resistance around the world. The plan hopes to curb the rise caused by an unchecked use of antibiotics and lack of new antibiotics on the market.

5 Jun 2015

Medical experts call for accurate, standardized estrogen testing methods

Unreliable estrogen measurements have had a negative impact on the treatment of and research into many hormone-related cancers and chronic conditions. To improve patient care, a panel of medical experts has called for accurate, standardized estrogen testing methods in a statement published in the Endocrine Society's Journal of Clinical Endocrinology & Metabolism.

5 Jun 2015

IDMC recommends continuation of Argos’ ADAPT phase 3 trial of AGS-003 in mRCC patients

Argos Therapeutics Inc., an immuno-oncology company focused on the development and commercialization of fully personalized immunotherapies for the treatment of cancer based on the Arcelis technology platform, today announced an independent data monitoring committee (IDMC) has recommended the continuation of the company’s pivotal phase 3 ADAPT clinical trial of AGS-003 for the treatment of metastatic renal cell carcinoma (mRCC) following the first of three planned interim data analyses.

5 Jun 2015

Boston Scientific announces European launch of Precision Novi SCS System

Boston Scientific announces the European launch of the Precision Novi Spinal Cord Stimulator (SCS) System at the International Neuromodulation Society in Montreal, Canada. The 16-contact primary cell device has CE Mark for the treatment of chronic pain, and is the smallest high-capacity primary cell device currently available.

5 Jun 2015

Device / Technology News

NGS mutational testing can help detect patients with Barrett's esophagus

Researchers develop device to diagnose bacterial meningitis in babies

Electroporation technique brings higher efficiency, higher throughput genome engineering in animal models

Simulator-based driver assessment differentiates between skilled and non-skilled drivers

Molecular Health, TestAnalytika sign distribution agreement for TreatmentMAP in Latin American region

EMR Direct's phiMail Server software achieves ONC-HIT 2014 Edition Modular Certification

Breathe NIOV System improves exercise duration among patients with chronic respiratory disease

Clinical data of Trovagene's Precision Cancer Monitoring platform to be presented at two medical conferences

Merck KGaA, Darmstadt, Germany forms Global Fertility Alliance with Illumina and Genea

Study: Non-invasive prenatal testing works in women at high risk of having babies with Down's syndrome

Non-invasive prenatal testing for Down's syndrome acceptable to parents

Non-invasive prenatal testing can detect maternal cancer at early stage

Mountain River Physical Therapy chooses Clinicient's PracticeInsight cloud-based EMR and billing software

Physicians at UH Case Medical Center implant revolutionary device to treat right ventricular heart disease

Seven NHS Trusts shortlisted for UK-wide healthcare award

Study can help spur beneficial lifestyle changes in patients to reduce Alzheimer's risk

New Tel Aviv University research introduces promising new tool to combat antibiotic-resistant pathogens

Medical experts call for accurate, standardized estrogen testing methods

IDMC recommends continuation of Argos’ ADAPT phase 3 trial of AGS-003 in mRCC patients

Boston Scientific announces European launch of Precision Novi SCS System

Advancing brain microphysiological systems (bMPS)

PhD researcher at LifeArc

Unveiling Hidden Potential: Organoids for Disease Modeling in Neuroscience Research

Latest News